{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:05:13Z","timestamp":1793397913507,"version":"4.5.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00213-020-05563-3","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T05:03:40Z","timestamp":1593407020000},"page":"2233-2255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6040-7708","authenticated-orcid":false,"given":"Vitor S.","family":"Tardelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4243-6462","authenticated-orcid":false,"given":"Adam","family":"Bisaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-5626","authenticated-orcid":false,"given":"Felipe B.","family":"Arcadepani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Gerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-1329","authenticated-orcid":false,"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3555-5228","authenticated-orcid":false,"given":"Thiago M.","family":"Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"5563_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jclinepi.2015.09.005","volume":"70","author":"AC Alba","year":"2016","unstructured":"Alba AC, Alexander PE, Chang J, MacIsaac J, DeFry S, Guyatt GH (2016) High statistical heterogeneity is more frequent in meta-analysis of continuous than binary outcomes. J Clin Epidemiol 70:129\u2013135","journal-title":"J Clin Epidemiol"},{"key":"5563_CR2","doi-asserted-by":"crossref","unstructured":"Amato L, Minozzi S, Pani PP, Solimini R, Vecchi S, Zuccaro P, Davoli M (2011) Dopamine agonists for the treatment of cocaine dependence. Cochrane Database Syst Rev:CD003352","DOI":"10.1002\/14651858.CD003352.pub3"},{"key":"5563_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00213-010-1839-2","volume":"210","author":"ML Andersen","year":"2010","unstructured":"Andersen ML, Kessler E, Murnane KS, McClung JC, Tufik S, Howell LL (2010) Dopamine transporter-related effects of modafinil in rhesus monkeys. Psychopharmacology (Berl) 210:439\u2013448","journal-title":"Psychopharmacology (Berl)"},{"key":"5563_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","volume":"104","author":"AL Anderson","year":"2009","unstructured":"Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, Ciraulo D, Dackis C, Roache JD, Salloum IM, Somoza E, Urschel HC 3rd, Elkashef AM (2009) Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend 104:133\u2013139","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","volume":"120","author":"AL Anderson","year":"2012","unstructured":"Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, Kahn R, Chiang N, Beresford T, Campbell J, Haning W, Mawhinney J, McCann M, Rawson R, Stock C, Weis D, Yu E, Elkashef AM (2012) Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend 120:135\u2013141","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR6","doi-asserted-by":"crossref","unstructured":"Anthony JC, Warner LA, Kessler RC (1997) Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey.","DOI":"10.1037\/10248-001"},{"key":"5563_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401\u2013406","journal-title":"J Clin Epidemiol"},{"key":"5563_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11121-013-0377-7","volume":"14","author":"M Borenstein","year":"2013","unstructured":"Borenstein M, Higgins JP (2013) Meta-analysis and subgroups. Prev Sci 14:134\u2013143","journal-title":"Prev Sci"},{"key":"5563_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.drugalcdep.2018.03.030","volume":"188","author":"RC Callaghan","year":"2018","unstructured":"Callaghan RC, Halliday M, Gatley J, Sykes J, Taylor L, Benny C, Kish SJ (2018) Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: a retrospective cohort study. Drug Alcohol Depend 188:259\u2013265","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.drugalcdep.2014.01.012","volume":"137","author":"KM Carroll","year":"2014","unstructured":"Carroll KM, Kiluk BD, Nich C, DeVito EE, Decker S, LaPaglia D, Duffey D, Babuscio TA, Ball SA (2014) Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes. Drug Alcohol Depend 137:3\u201319","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR11","first-page":"CD007380","volume":"9","author":"X Castells","year":"2016","unstructured":"Castells X, Cunill R, Perez-Mana C, Vidal X, Capella D (2016) Psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev 9:CD007380","journal-title":"Cochrane Database Syst Rev"},{"key":"5563_CR12","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","volume":"34","author":"B Chan","year":"2019","unstructured":"Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, Kansagara D (2019) Pharmacotherapy for cocaine use disorder\u2014a systematic review and meta-analysis. J Gen Intern Med. 34:2858\u20132873","journal-title":"J Gen Intern Med."},{"key":"5563_CR13","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","volume":"365","author":"WO Cooper","year":"2011","unstructured":"Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (2011) ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365:1896\u20131904","journal-title":"N Engl J Med"},{"key":"5563_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/pr.115.011668","volume":"68","author":"PW Czoty","year":"2016","unstructured":"Czoty PW, Stoops WW, Rush CR (2016) Evaluation of the \"pipeline\" for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research. Pharmacol Rev 68:533\u2013562","journal-title":"Pharmacol Rev"},{"key":"5563_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.npp.1300600","volume":"30","author":"CA Dackis","year":"2005","unstructured":"Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30:205\u2013211","journal-title":"Neuropsychopharmacology"},{"key":"5563_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","volume":"43","author":"CA Dackis","year":"2012","unstructured":"Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T, O'Brien CP (2012) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat 43:303\u2013312","journal-title":"J Subst Abuse Treat"},{"key":"5563_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/add.13158","volume":"111","author":"S Darke","year":"2016","unstructured":"Darke S, Farrell M (2016) Which medications are suitable for agonist drug maintenance? Addiction 111:767\u2013774","journal-title":"Addiction"},{"key":"5563_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/eb-2016-102415","volume":"20","author":"F De Crescenzo","year":"2017","unstructured":"De Crescenzo F, Cortese S, Adamo N, Janiri L (2017) Pharmacological and non-pharmacological treatment of adults with ADHD: a meta-review. Evid Based Ment Health 20:4\u201311","journal-title":"Evid Based Ment Health"},{"key":"5563_CR19","first-page":"233","volume":"53","author":"R De Giorgi","year":"2018","unstructured":"De Giorgi R, Cassar C, Loreto D'alo G, Ciabattini M, Minozzi S, Economou A, Tambelli R, Lucchese F, Saulle R, Amato L, Janiri L, De Crescenzo F (2018) Psychosocial interventions in stimulant use disorders: a systematic review and qualitative synthesis of randomized controlled trials. Riv Psichiatr 53:233\u2013255","journal-title":"Riv Psichiatr"},{"key":"5563_CR20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/sim.1188","volume":"21","author":"JJ Deeks","year":"2002","unstructured":"Deeks JJ (2002) Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 21:1575\u20131600","journal-title":"Stat Med"},{"key":"5563_CR21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1473-3099(16)30325-5","volume":"16","author":"L Degenhardt","year":"2016","unstructured":"Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, Cowie B, Hall WD, Strang J, Whiteford H, Vos T (2016) Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis 16:1385\u20131398","journal-title":"Lancet Infect Dis"},{"key":"5563_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/JCP.0b013e31827bfff4","volume":"33","author":"KM Dursteler-MacFarland","year":"2013","unstructured":"Dursteler-MacFarland KM, Farronato NS, Strasser J, Boss J, Kuntze MF, Petitjean SA, Burki C, Wiesbeck GA (2013) A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription. J Clin Psychopharmacol 33:104\u2013108","journal-title":"J Clin Psychopharmacol"},{"key":"5563_CR23","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P","volume":"19","author":"EA Engels","year":"2000","unstructured":"Engels EA, Schmid CH, Terrin N, Olkin I, Lau J (2000) Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med 19:1707\u20131728","journal-title":"Stat Med"},{"key":"5563_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020723","volume":"8","author":"N Ezard","year":"2018","unstructured":"Ezard N, Dunlop A, Hall M, Ali R, McKetin R, Bruno R, Phung N, Carr A, White J, Clifford B, Liu Z, Shanahan M, Dolan K, Baker AL, Lintzeris N (2018) LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence. BMJ Open 8:e020723","journal-title":"BMJ Open"},{"key":"5563_CR25","doi-asserted-by":"crossref","unstructured":"Faggiano F, Vigna-Taglianti F, Versino E, Lemma P (2003) Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev:CD002208","DOI":"10.1002\/14651858.CD002208"},{"key":"5563_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00787-009-0054-3","volume":"19","author":"SV Faraone","year":"2010","unstructured":"Faraone SV, Buitelaar J (2010) Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry 19:353\u2013364","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"5563_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/1874473711104040228","volume":"4","author":"A Fiorentini","year":"2011","unstructured":"Fiorentini A, Volonteri LS, Dragogna F, Rovera C, Maffini M, Mauri MC, Altamura CA (2011) Substance-induced psychoses: a critical review of the literature. Curr Drug Abuse Rev 4:228\u2013240","journal-title":"Curr Drug Abuse Rev"},{"key":"5563_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/00952990.2013.772618","volume":"39","author":"L Florez-Salamanca","year":"2013","unstructured":"Florez-Salamanca L, Secades-Villa R, Hasin DS, Cottler L, Wang S, Grant BF, Blanco C (2013) Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Drug Alcohol Abuse 39:168\u2013179","journal-title":"Am J Drug Alcohol Abuse"},{"key":"5563_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/clpt.2010.307","volume":"89","author":"GP Galloway","year":"2011","unstructured":"Galloway GP, Buscemi R, Coyle JR, Flower K, Siegrist JD, Fiske LA, Baggott MJ, Li L, Polcin D, Chen CY, Mendelson J (2011) A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther 89:276\u2013282","journal-title":"Clin Pharmacol Ther"},{"key":"5563_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1037\/a0015963","volume":"17","author":"O Garcia-Rodriguez","year":"2009","unstructured":"Garcia-Rodriguez O, Secades-Villa R, Higgins ST, Fernandez-Hermida JR, Carballo JL, Errasti Perez JM, Al-halabi Diaz S (2009) Effects of voucher-based intervention on abstinence and retention in an outpatient treatment for cocaine addiction: a randomized controlled trial. Exp Clin Psychopharmacol 17:131\u2013138","journal-title":"Exp Clin Psychopharmacol"},{"key":"5563_CR31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/npp.2010.145","volume":"36","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein RZ, Volkow ND (2011) Oral methylphenidate normalizes cingulate activity and decreases impulsivity in cocaine addiction during an emotionally salient cognitive task. Neuropsychopharmacology 36:366\u2013367","journal-title":"Neuropsychopharmacology"},{"key":"5563_CR32","doi-asserted-by":"publisher","first-page":"16667","DOI":"10.1073\/pnas.1011455107","volume":"107","author":"RZ Goldstein","year":"2010","unstructured":"Goldstein RZ, Woicik PA, Maloney T, Tomasi D, Alia-Klein N, Shan J, Honorio J, Samaras D, Wang R, Telang F, Wang GJ, Volkow ND (2010) Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. Proc Natl Acad Sci U S A 107:16667\u201316672","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5563_CR33","first-page":"436","volume":"141","author":"J Grabowski","year":"1994","unstructured":"Grabowski J, Schmitz J, Roache J, Rhoades H, Elk R, Creson D (1994) Methylphenidate (MP) for initial treatment of cocaine dependence and a model for medication evaluation. NIDA Research Monograph 141:436\u2013436","journal-title":"NIDA Research Monograph"},{"key":"5563_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00004714-199712000-00008","volume":"17","author":"J Grabowski","year":"1997","unstructured":"Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A (1997) Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 17:485\u2013488","journal-title":"J Clin Psychopharmacol"},{"key":"5563_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","volume":"21","author":"J Grabowski","year":"2001","unstructured":"Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, Moeller FG (2001) Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21:522\u2013526","journal-title":"J Clin Psychopharmacol"},{"key":"5563_CR36","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/sj.npp.1300392","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, Moeller FG, Hassan S, Schmitz J (2004) Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29:969\u2013981","journal-title":"Neuropsychopharmacology"},{"key":"5563_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","volume":"73","author":"BF Grant","year":"2016","unstructured":"Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, Zhang H, Smith SM, Pickering RP, Huang B, Hasin DS (2016) Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions\u2014III. JAMA Psychiatry 73:39\u201347","journal-title":"JAMA Psychiatry"},{"key":"5563_CR38","first-page":"206","volume":"44","author":"JD Griffith","year":"1983","unstructured":"Griffith JD, Carranza J, Griffith C, Miller LL (1983) Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry 44:206\u2013208","journal-title":"J Clin Psychiatry"},{"key":"5563_CR39","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2011.1830","volume":"306","author":"LA Habel","year":"2011","unstructured":"Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV (2011) ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 306:2673\u20132683","journal-title":"JAMA"},{"key":"5563_CR40","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/add.12633","volume":"109","author":"J Hartmann-Boyce","year":"2014","unstructured":"Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T (2014) Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction 109:1414\u20131425","journal-title":"Addiction"},{"key":"5563_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.drugalcdep.2009.11.023","volume":"109","author":"KG Heinzerling","year":"2010","unstructured":"Heinzerling KG, Swanson AN, Kim S, Cederblom L, Moe A, Ling W, Shoptaw S (2010) Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend 109:20\u201329","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/JAN.0000000000000058","volume":"26","author":"TL Hellem","year":"2015","unstructured":"Hellem TL, Lundberg KJ, Renshaw PF (2015) A review of treatment options for co-occurring methamphetamine use disorders and depression. J Addict Nurs 26:14\u201323 quiz E1","journal-title":"J Addict Nurs"},{"key":"5563_CR43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1749-6632.2009.05145.x","volume":"1187","author":"DV Herin","year":"2010","unstructured":"Herin DV, Rush CR, Grabowski J (2010) Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann N Y Acad Sci 1187:76\u2013100","journal-title":"Ann N Y Acad Sci"},{"key":"5563_CR44","unstructured":"Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011"},{"key":"5563_CR45","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods G, Cochrane Statistical Methods G (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"5563_CR46","volume":"3","author":"BI Indave","year":"2016","unstructured":"Indave BI, Minozzi S, Pani PP, Amato L (2016) Antipsychotic medications for cocaine dependence. Cochrane Database Syst Rev 3:CD006306","journal-title":"Cochrane Database Syst Rev"},{"key":"5563_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/026988110001400107","volume":"14","author":"DR Jasinski","year":"2000","unstructured":"Jasinski DR (2000) An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacology 14:53\u201360","journal-title":"J Psychopharmacology"},{"key":"5563_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JCP.0000000000000446","volume":"36","author":"JM Jerry","year":"2016","unstructured":"Jerry JM, Shirvani N, Dale R (2016) Addiction to armodafinil and modafinil presenting with paranoia. J Clin Psychopharmacol 36:98\u2013100","journal-title":"J Clin Psychopharmacol"},{"key":"5563_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/sj.npp.1301564","volume":"33","author":"PW Kalivas","year":"2008","unstructured":"Kalivas PW, O'Brien C (2008) Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33:166\u2013180","journal-title":"Neuropsychopharmacology"},{"key":"5563_CR50","doi-asserted-by":"publisher","first-page":"eaax1532","DOI":"10.1126\/sciadv.aax1532","volume":"5","author":"KM Kampman","year":"2019","unstructured":"Kampman KM (2019) The treatment of cocaine use disorder. Sci Adv 5:eaax1532","journal-title":"Sci Adv"},{"key":"5563_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","volume":"155","author":"KM Kampman","year":"2015","unstructured":"Kampman KM, Lynch KG, Pettinati HM, Spratt K, Wierzbicki MR, Dackis C, O'Brien CP (2015) A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug Alcohol Depend 155:105\u2013110","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1017\/S1461145713001612","volume":"17","author":"W Kim","year":"2014","unstructured":"Kim W, Tateno A, Arakawa R, Sakayori T, Ikeda Y, Suzuki H, Okubo Y (2014) In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [(1)(8)F]FE-PE2I. Int J Neuropsychopharmacol 17:697\u2013703","journal-title":"Int J Neuropsychopharmacol"},{"key":"5563_CR53","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.11.006","volume":"108","author":"M Konstenius","year":"2010","unstructured":"Konstenius M, Jayaram-Lindstrom N, Beck O, Franck J (2010) Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend 108:130\u2013133","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR54","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/add.12369","volume":"109","author":"M Konstenius","year":"2014","unstructured":"Konstenius M, Jayaram-Lindstrom N, Guterstam J, Beck O, Philips B, Franck J (2014) Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction 109:440\u2013449","journal-title":"Addiction"},{"key":"5563_CR55","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","volume":"54","author":"SM Learned-Coughlin","year":"2003","unstructured":"Learned-Coughlin SM, Bergstrom M, Savitcheva I, Ascher J, Schmith VD, Langstrom B (2003) In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 54:800\u2013805","journal-title":"Biol Psychiatry"},{"key":"5563_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/09595230801919494","volume":"27","author":"NK Lee","year":"2008","unstructured":"Lee NK, Rawson RA (2008) A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 27:309\u2013317","journal-title":"Drug Alcohol Rev"},{"key":"5563_CR57","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cpr.2011.01.006","volume":"31","author":"SS Lee","year":"2011","unstructured":"Lee SS, Humphreys KL, Flory K, Liu R, Glass K (2011) Prospective association of childhood attention-deficit\/hyperactivity disorder (ADHD) and substance use and abuse\/dependence: a meta-analytic review. Clin Psychol Rev 31:328\u2013341","journal-title":"Clin Psychol Rev"},{"key":"5563_CR58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.drugalcdep.2005.06.012","volume":"81","author":"FR Levin","year":"2006","unstructured":"Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV (2006) Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 81:137\u2013148","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.drugalcdep.2006.07.004","volume":"87","author":"FR Levin","year":"2007","unstructured":"Levin FR, Evans SM, Brooks DJ, Garawi F (2007) Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 87:20\u201329","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR60","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/add.12885","volume":"110","author":"FR Levin","year":"2015","unstructured":"Levin FR, Mariani JJ, Bisaga A, Nunes EV (2015a) Ling et al.\u2019s \u2018sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder\u2019. Addiction 110:875\u2013876","journal-title":"Addiction"},{"key":"5563_CR61","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","volume":"72","author":"FR Levin","year":"2015","unstructured":"Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J (2015b) Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: a randomized clinical trial. JAMA Psychiatry 72:593\u2013602","journal-title":"JAMA Psychiatry"},{"key":"5563_CR62","doi-asserted-by":"publisher","first-page":"107700","DOI":"10.1016\/j.drugalcdep.2019.107700","volume":"206","author":"FR Levin","year":"2020","unstructured":"Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Mahony AL, Brooks DJ, Bisaga A, Dakwar E, Carpenter KM, Naqvi N, Nunes EV, Kampman K (2020) Extended release mixed amphetamine salts and topiramate for cocaine dependence: a randomized clinical replication trial with frequent users. Drug Alcohol Depend 206:107700","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR63","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1111\/add.12608","volume":"109","author":"W Ling","year":"2014","unstructured":"Ling W, Chang L, Hillhouse M, Ang A, Striebel J, Jenkins J, Hernandez J, Olaer M, Mooney L, Reed S, Fukaya E, Kogachi S, Alicata D, Holmes N, Esagoff A (2014) Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction 109:1489\u20131500","journal-title":"Addiction"},{"key":"5563_CR64","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2014.10.044","volume":"1628","author":"ED London","year":"2015","unstructured":"London ED, Kohno M, Morales AM, Ballard ME (2015) Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res 1628:174\u2013185","journal-title":"Brain Res"},{"key":"5563_CR65","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1360-0443.2009.02717.x","volume":"105","author":"M Longo","year":"2010","unstructured":"Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM (2010) Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction 105:146\u2013154","journal-title":"Addiction"},{"key":"5563_CR66","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","volume":"101","author":"JP Lussier","year":"2006","unstructured":"Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST (2006) A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 101:192\u2013203","journal-title":"Addiction"},{"key":"5563_CR67","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1124\/jpet.106.106583","volume":"319","author":"BK Madras","year":"2006","unstructured":"Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ (2006) Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319:561\u2013569","journal-title":"J Pharmacol Exp Ther"},{"key":"5563_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","volume":"108","author":"NC Maisel","year":"2013","unstructured":"Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108:275\u2013293","journal-title":"Addiction"},{"key":"5563_CR69","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.psc.2012.03.012","volume":"35","author":"JJ Mariani","year":"2012","unstructured":"Mariani JJ, Levin FR (2012) Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am 35:425\u2013439","journal-title":"Psychiatr Clin North Am"},{"key":"5563_CR70","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.biopsych.2012.05.032","volume":"72","author":"JJ Mariani","year":"2012","unstructured":"Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR (2012) Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry 72:950\u2013956","journal-title":"Biol Psychiatry"},{"key":"5563_CR71","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0140-6736(09)61420-3","volume":"374","author":"J Marsden","year":"2009","unstructured":"Marsden J, Eastwood B, Bradbury C, Dale-Perera A, Farrell M, Hammond P, Knight J, Randhawa K, Wright C, National Drug Treatment Monitoring System Outcomes Study G (2009) Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study. Lancet 374:1262\u20131270","journal-title":"Lancet"},{"key":"5563_CR72","doi-asserted-by":"publisher","first-page":"A11","DOI":"10.7326\/ACPJC-2003-138-2-A11","volume":"138","author":"A Marx","year":"2003","unstructured":"Marx A, Bucher HC (2003) Numbers needed to treat derived from meta-analysis: a word of caution. ACP J Club 138:A11\u2013A12","journal-title":"ACP J Club"},{"key":"5563_CR73","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev:CD002209","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"5563_CR74","unstructured":"McMaster University (developed by Evidence Prime I (2015) GRADEpro GDT: GRADEpro Guideline Development Tool [Software]"},{"key":"5563_CR75","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00213-002-1166-3","volume":"163","author":"JH Meyer","year":"2002","unstructured":"Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S (2002) Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology (Berl) 163:102\u2013105","journal-title":"Psychopharmacology (Berl)"},{"key":"5563_CR76","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1037\/adb0000192","volume":"30","author":"AQ Miguel","year":"2016","unstructured":"Miguel AQ, Madruga CS, Cogo-Moreira H, Yamauchi R, Simoes V, da Silva CJ, McPherson S, Roll JM, Laranjeira RR (2016) Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: a randomized controlled trial. Psychol Addict Behav 30:536\u2013543","journal-title":"Psychol Addict Behav"},{"key":"5563_CR77","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.drugalcdep.2019.01.046","volume":"198","author":"AQC Miguel","year":"2019","unstructured":"Miguel AQC, Kiluk BD, Babuscio TA, Nich C, Mari JJ, Carroll KM (2019) Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders. Drug Alcohol Depend 198:126\u2013132","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR78","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/add.12109","volume":"108","author":"SW Miles","year":"2013","unstructured":"Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Fohr J, Kuikanmaki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J (2013) Extended-release methylphenidate for treatment of amphetamine\/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction 108:1279\u20131286","journal-title":"Addiction"},{"key":"5563_CR79","volume":"9","author":"S Minozzi","year":"2016","unstructured":"Minozzi S, Saulle R, De Crescenzo F, Amato L (2016) Psychosocial interventions for psychostimulant misuse. Cochrane Database Syst Rev 9:CD011866","journal-title":"Cochrane Database Syst Rev"},{"key":"5563_CR80","unstructured":"Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence (n.d.) https:\/\/ClinicalTrials.gov\/show\/NCT00142818"},{"key":"5563_CR81","unstructured":"Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction\u20141 (n.d.) https:\/\/ClinicalTrials.gov\/show\/NCT00218387"},{"key":"5563_CR82","unstructured":"Modafinil for Methamphetamine Dependence (n.d.) https:\/\/ClinicalTrials.gov\/show\/NCT00859573"},{"key":"5563_CR83","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006\u20131012","journal-title":"J Clin Epidemiol"},{"key":"5563_CR84","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","volume":"101","author":"ME Mooney","year":"2009","unstructured":"Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J (2009) Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 101:34\u201341","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR85","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugalcdep.2015.05.042","volume":"153","author":"ME Mooney","year":"2015","unstructured":"Mooney ME, Herin DV, Specker S, Babb D, Levin FR, Grabowski J (2015) Pilot study of the effects of lisdexamfetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 153:94\u2013103","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR86","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.drugalcdep.2015.12.004","volume":"160","author":"PT Morgan","year":"2016","unstructured":"Morgan PT, Angarita GA, Canavan S, Pittman B, Oberleitner L, Malison RT, Mohsenin V, Hodges S, Easton C, McKee S, Bessette A, Forselius E (2016) Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence. Drug Alcohol Depend 160:49\u201356","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR87","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","volume":"341","author":"E Nuesch","year":"2010","unstructured":"Nuesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, Egger M, Juni P (2010) Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 341:c3515","journal-title":"BMJ"},{"key":"5563_CR88","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/S0140-6736(16)00205-1","volume":"387","author":"M Nuijten","year":"2016","unstructured":"Nuijten M, Blanken P, van de Wetering B, Nuijen B, van den Brink W, Hendriks VM (2016) Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial. Lancet 387:2226\u20132234","journal-title":"Lancet"},{"key":"5563_CR89","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","volume":"116","author":"AD Oxman","year":"1992","unstructured":"Oxman AD, Guyatt GH (1992) A consumer's guide to subgroup analyses. Ann Intern Med 116:78\u201384","journal-title":"Ann Intern Med"},{"key":"5563_CR90","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874473711003010049","volume":"3","author":"JK Penberthy","year":"2010","unstructured":"Penberthy JK, Ait-Daoud N, Vaughan M, Fanning T (2010) Review of treatment for cocaine dependence. Curr Drug Abuse Rev 3:49\u201362","journal-title":"Curr Drug Abuse Rev"},{"key":"5563_CR91","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Ma\u00f1\u00e1 C, Llonch C, Farre M (2012) Transparency in clinical research: registration of clinical trials and publication of results. Med Clin (Barc) 139:593\u2013597","DOI":"10.1016\/j.medcli.2012.06.009"},{"key":"5563_CR92","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Ma\u00f1\u00e1 C, Castells X, Torrens M, Capella D, Farre M (2013) Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database Syst Rev:CD009695","DOI":"10.1002\/14651858.CD009695.pub2"},{"key":"5563_CR93","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/archpsyc.62.10.1148","volume":"62","author":"NM Petry","year":"2005","unstructured":"Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R (2005) Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 62:1148\u20131156","journal-title":"Arch Gen Psychiatry"},{"key":"5563_CR94","unstructured":"Pharmacotherapy & CM for Opioid and Cocaine Dependence (n.d.) https:\/\/ClinicalTrials.gov\/show\/NCT00838981"},{"key":"5563_CR95","unstructured":"Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals\u20148 (n.d.) https:\/\/ClinicalTrials.gov\/show\/NCT00218036"},{"key":"5563_CR96","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40199-015-0092-y","volume":"23","author":"F Rezaei","year":"2015","unstructured":"Rezaei F, Emami M, Zahed S, Morabbi MJ, Farahzadi M, Akhondzadeh S (2015) Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial. Daru 23:2","journal-title":"Daru"},{"key":"5563_CR97","doi-asserted-by":"publisher","first-page":"107648","DOI":"10.1016\/j.drugalcdep.2019.107648","volume":"205","author":"CR Roos","year":"2019","unstructured":"Roos CR, Nich C, Mun CJ, Babuscio TA, Mendonca J, Miguel AQC, DeVito EE, Yip SW, Witkiewitz K, Carroll KM, Kiluk BD (2019a) Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder. Drug Alcohol Depend 205:107648","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR98","doi-asserted-by":"publisher","first-page":"431","DOI":"10.15288\/jsad.2019.80.431","volume":"80","author":"CR Roos","year":"2019","unstructured":"Roos CR, Nich C, Mun CJ, Mendonca J, Babuscio TA, Witkiewitz K, Carroll KM, Kiluk BD (2019b) Patterns of cocaine use during treatment: associations with baseline characteristics and follow-up functioning. J Stud Alcohol Drugs 80:431\u2013440","journal-title":"J Stud Alcohol Drugs"},{"key":"5563_CR99","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.biopsych.2004.05.009","volume":"56","author":"BJ Rounsaville","year":"2004","unstructured":"Rounsaville BJ (2004) Treatment of cocaine dependence and depression. Biol Psychiatry 56:803\u2013809","journal-title":"Biol Psychiatry"},{"key":"5563_CR100","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/archpsyc.1991.01810250045005","volume":"48","author":"BJ Rounsaville","year":"1991","unstructured":"Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F (1991) Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48:43\u201351","journal-title":"Arch Gen Psychiatry"},{"key":"5563_CR101","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1037\/1064-1297.9.1.59","volume":"9","author":"CR Rush","year":"2001","unstructured":"Rush CR, Baker RW (2001) Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol 9:59\u201373","journal-title":"Exp Clin Psychopharmacol"},{"key":"5563_CR102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4155\/fmc.11.184","volume":"4","author":"CR Rush","year":"2012","unstructured":"Rush CR, Stoops WW (2012) Agonist replacement therapy for cocaine dependence: a translational review. Future Med Chem 4:245\u2013265","journal-title":"Future Med Chem"},{"key":"5563_CR103","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.drugalcdep.2018.08.041","volume":"194","author":"S Sabrini","year":"2019","unstructured":"Sabrini S, Wang GY, Lin JC, Ian JK, Curley LE (2019) Methamphetamine use and cognitive function: a systematic review of neuroimaging research. Drug Alcohol Depend 194:75\u201387","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fpsyt.2012.00077","volume":"3","author":"JM Schmitz","year":"2012","unstructured":"Schmitz JM, Rathnayaka N, Green CE, Moeller FG, Dougherty AE, Grabowski J (2012) Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation. Front Psychiatry 3:77","journal-title":"Front Psychiatry"},{"key":"5563_CR105","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.drugalcdep.2013.12.015","volume":"136","author":"JM Schmitz","year":"2014","unstructured":"Schmitz JM, Green CE, Stotts AL, Lindsay JA, Rathnayaka NS, Grabowski J, Moeller FG (2014) A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone. Drug Alcohol Depend 136:100\u2013107","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR106","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1037\/1064-1297.10.3.286","volume":"10","author":"H Schubiner","year":"2002","unstructured":"Schubiner H, Saules KK, Arfken CL, Johanson CE, Schuster CR, Lockhart N, Edwards A, Donlin J, Pihlgren E (2002) Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10:286\u2013294","journal-title":"Exp Clin Psychopharmacol"},{"key":"5563_CR107","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJMra1604339","volume":"375","author":"MA Schuckit","year":"2016","unstructured":"Schuckit MA (2016) Treatment of opioid-use disorders. N Engl J Med 375:357\u2013368","journal-title":"N Engl J Med"},{"key":"5563_CR108","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/09595230801927372","volume":"27","author":"J Shearer","year":"2008","unstructured":"Shearer J (2008) The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev 27:301\u2013308","journal-title":"Drug Alcohol Rev"},{"key":"5563_CR109","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/09595230220139082","volume":"21","author":"J Shearer","year":"2002","unstructured":"Shearer J, Sherman J, Wodak A, van Beek I (2002) Substitution therapy for amphetamine users. Drug Alcohol Rev 21:179\u2013185","journal-title":"Drug Alcohol Rev"},{"key":"5563_CR110","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1046\/j.1360-0443.2003.00447.x","volume":"98","author":"J Shearer","year":"2003","unstructured":"Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J (2003) Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98:1137\u20131141","journal-title":"Addiction"},{"key":"5563_CR111","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","volume":"104","author":"J Shearer","year":"2009","unstructured":"Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A (2009) A double-blind, placebo-controlled trial of modafinil (200 mg\/day) for methamphetamine dependence. Addiction 104:224\u2013233","journal-title":"Addiction"},{"key":"5563_CR112","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/add.13328","volume":"111","author":"M Singh","year":"2016","unstructured":"Singh M, Keer D, Klimas J, Wood E, Werb D (2016) Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials. Addiction 111:1337\u20131346","journal-title":"Addiction"},{"key":"5563_CR113","doi-asserted-by":"publisher","first-page":"7026","DOI":"10.2174\/138161281940131209142843","volume":"19","author":"WW Stoops","year":"2013","unstructured":"Stoops WW, Rush CR (2013) Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm Des 19:7026\u20137035","journal-title":"Curr Pharm Des"},{"key":"5563_CR114","unstructured":"Substance Abuse Mental Health Services Administration (2019) Key substance use and mental health indicators in the United States: results from the 2018 National Survey on Drug Use and Health. Rockville, MD: (HHS Publication No PEP19-5068, NSDUH Series H-54), Rockville, MD: Center for Behavioral Health Statistics and Quality"},{"key":"5563_CR115","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brat.2018.10.002","volume":"111","author":"VS Tardelli","year":"2018","unstructured":"Tardelli VS, Lago M, Mendez M, Bisaga A, Fidalgo TM (2018) Contingency management with pharmacologic treatment for stimulant use disorders: a review. Behav Res Ther 111:57\u201363","journal-title":"Behav Res Ther"},{"key":"5563_CR116","unstructured":"The Nordic Cochrane Centre TCC (2014) Review Manager (RevMan) [Computer program] Version 5.3"},{"key":"5563_CR117","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/ajp.2007.164.1.160","volume":"164","author":"J Tiihonen","year":"2007","unstructured":"Tiihonen J, Kuoppasalmi K, Fohr J, Tuomola P, Kuikanmaki O, Vorma H, Sokero P, Haukka J, Meririnne E (2007) A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry 164:160\u2013162","journal-title":"Am J Psychiatry"},{"key":"5563_CR118","unstructured":"United Nations Office on Drugs and Crime (2019) World drug report 2019"},{"key":"5563_CR119","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.drugalcdep.2013.09.026","volume":"134","author":"G van de Glind","year":"2014","unstructured":"van de Glind G, Konstenius M, Koeter MWJ, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitany-Foveny M, Fatseas M, Auriacombe M, Schillinger A, Moller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Group IR, Levin FR, van den Brink W (2014) Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend 134:158\u2013166","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR120","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugalcdep.2011.12.007","volume":"122","author":"K van Emmerik-van Oortmerssen","year":"2012","unstructured":"van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA (2012) Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 122:11\u201319","journal-title":"Drug Alcohol Depend"},{"key":"5563_CR121","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/SMJ.0b013e31817a7ee4","volume":"101","author":"AJ Viera","year":"2008","unstructured":"Viera AJ (2008) Odds ratios and risk ratios: what's the difference and why does it matter? South Med J 101:730\u2013734","journal-title":"South Med J"},{"key":"5563_CR122","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jama.2009.351","volume":"301","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301:1148\u20131154","journal-title":"JAMA"},{"key":"5563_CR123","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/j.1360-0443.2004.00884.x","volume":"99","author":"RD Weiss","year":"2004","unstructured":"Weiss RD (2004) Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction 99:1382\u20131392","journal-title":"Addiction"},{"key":"5563_CR124","first-page":"149","volume":"17","author":"LS Woon","year":"2018","unstructured":"Woon LS, Hazli Z, Gan LLY (2018) Pharmacotherapy for comorbid adult attention-deficit hyperactivity disorder and stimulant dependence: a systematic review. International Medical Journal Malaysia 17:149\u2013161","journal-title":"International Medical Journal Malaysia"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05563-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05563-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T06:06:04Z","timestamp":1650521164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05563-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":124,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["5563"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05563-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"8 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present article does not necessarily express the view of the United Nations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}